Concepts (283)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Catheter Ablation | 2 | 2023 | 113 | 1.330 |
Why?
|
| Coronary Artery Bypass | 14 | 2017 | 100 | 1.140 |
Why?
|
| Thoracoscopy | 2 | 2018 | 11 | 1.050 |
Why?
|
| Atrial Fibrillation | 4 | 2020 | 410 | 0.920 |
Why?
|
| Propofol | 2 | 2022 | 20 | 0.830 |
Why?
|
| Cardiac Tamponade | 1 | 2023 | 10 | 0.810 |
Why?
|
| Atrial Flutter | 1 | 2023 | 20 | 0.810 |
Why?
|
| Hemodynamics | 15 | 2023 | 164 | 0.790 |
Why?
|
| Methohexital | 1 | 2022 | 7 | 0.750 |
Why?
|
| Vasoconstriction | 1 | 2022 | 42 | 0.750 |
Why?
|
| Humans | 56 | 2023 | 32282 | 0.700 |
Why?
|
| Intubation, Intratracheal | 3 | 2017 | 56 | 0.680 |
Why?
|
| Goals | 1 | 2020 | 34 | 0.630 |
Why?
|
| Bronchoscopy | 2 | 2017 | 54 | 0.580 |
Why?
|
| Prospective Studies | 12 | 2023 | 2316 | 0.580 |
Why?
|
| Aorta, Thoracic | 1 | 2019 | 81 | 0.570 |
Why?
|
| Cardiology | 1 | 2019 | 104 | 0.550 |
Why?
|
| Stents | 2 | 2008 | 159 | 0.510 |
Why?
|
| Bronchi | 1 | 2017 | 33 | 0.510 |
Why?
|
| Postoperative Complications | 6 | 2017 | 823 | 0.490 |
Why?
|
| Cardiotonic Agents | 9 | 2006 | 41 | 0.460 |
Why?
|
| Collateral Circulation | 1 | 2015 | 10 | 0.450 |
Why?
|
| Coronary Thrombosis | 3 | 2009 | 12 | 0.440 |
Why?
|
| Coronary Circulation | 1 | 2015 | 41 | 0.440 |
Why?
|
| Cardiac Surgical Procedures | 5 | 2011 | 77 | 0.410 |
Why?
|
| Heart Failure | 2 | 2020 | 728 | 0.410 |
Why?
|
| Blood Loss, Surgical | 2 | 2011 | 50 | 0.410 |
Why?
|
| Myocardial Ischemia | 5 | 2002 | 98 | 0.370 |
Why?
|
| Coronary Vessels | 2 | 2015 | 174 | 0.360 |
Why?
|
| Coronary Artery Disease | 1 | 2015 | 427 | 0.350 |
Why?
|
| Epinephrine | 7 | 1998 | 44 | 0.350 |
Why?
|
| Pulmonary Atelectasis | 1 | 2011 | 3 | 0.340 |
Why?
|
| Respiratory Mechanics | 1 | 2011 | 6 | 0.340 |
Why?
|
| Antifibrinolytic Agents | 1 | 2011 | 14 | 0.340 |
Why?
|
| Mediastinal Neoplasms | 1 | 2011 | 15 | 0.340 |
Why?
|
| Intraoperative Complications | 2 | 2011 | 55 | 0.340 |
Why?
|
| Cardiopulmonary Bypass | 10 | 2007 | 56 | 0.340 |
Why?
|
| Male | 35 | 2023 | 19441 | 0.320 |
Why?
|
| Amrinone | 5 | 1998 | 5 | 0.310 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 541 | 0.290 |
Why?
|
| Middle Aged | 28 | 2017 | 11851 | 0.290 |
Why?
|
| Anesthesia | 4 | 2011 | 63 | 0.280 |
Why?
|
| Oxygen | 4 | 2020 | 138 | 0.280 |
Why?
|
| Adrenergic beta-Antagonists | 4 | 1999 | 59 | 0.280 |
Why?
|
| Risk Factors | 5 | 2020 | 3934 | 0.280 |
Why?
|
| Perioperative Care | 1 | 2008 | 51 | 0.270 |
Why?
|
| Heart Rate | 11 | 2007 | 362 | 0.270 |
Why?
|
| Surgical Procedures, Operative | 1 | 2008 | 79 | 0.260 |
Why?
|
| Dobutamine | 5 | 1998 | 54 | 0.260 |
Why?
|
| Catheterization, Central Venous | 1 | 2007 | 62 | 0.250 |
Why?
|
| Aged, 80 and over | 6 | 2023 | 3900 | 0.250 |
Why?
|
| Electric Countershock | 2 | 2022 | 18 | 0.250 |
Why?
|
| Female | 31 | 2017 | 19945 | 0.220 |
Why?
|
| Postural Balance | 1 | 2016 | 142 | 0.210 |
Why?
|
| Dopamine | 3 | 2006 | 262 | 0.210 |
Why?
|
| Pesticides | 1 | 2016 | 135 | 0.210 |
Why?
|
| Occupational Exposure | 1 | 2016 | 159 | 0.210 |
Why?
|
| Positive-Pressure Respiration | 1 | 2023 | 14 | 0.210 |
Why?
|
| Transients and Migrants | 1 | 2016 | 197 | 0.210 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 198 | 0.200 |
Why?
|
| Pulmonary Circulation | 1 | 2022 | 4 | 0.190 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2002 | 4 | 0.190 |
Why?
|
| Fentanyl | 5 | 1991 | 33 | 0.180 |
Why?
|
| Postoperative Care | 2 | 2007 | 79 | 0.180 |
Why?
|
| Propanolamines | 2 | 1999 | 12 | 0.170 |
Why?
|
| Postoperative Period | 3 | 2017 | 95 | 0.170 |
Why?
|
| Aged | 17 | 2017 | 10263 | 0.170 |
Why?
|
| Hispanic Americans | 1 | 2016 | 772 | 0.170 |
Why?
|
| Lung | 1 | 2022 | 263 | 0.170 |
Why?
|
| Nitroglycerin | 1 | 2000 | 10 | 0.160 |
Why?
|
| Electrocardiography, Ambulatory | 2 | 1997 | 28 | 0.160 |
Why?
|
| Vasodilator Agents | 1 | 2000 | 62 | 0.160 |
Why?
|
| Cardiac Pacing, Artificial | 3 | 2007 | 13 | 0.160 |
Why?
|
| Consensus | 1 | 2019 | 87 | 0.150 |
Why?
|
| Anesthetics | 2 | 1989 | 21 | 0.150 |
Why?
|
| Aorta | 1 | 2019 | 125 | 0.140 |
Why?
|
| Coronary Restenosis | 2 | 2008 | 15 | 0.140 |
Why?
|
| Isoproterenol | 2 | 1997 | 17 | 0.140 |
Why?
|
| Double-Blind Method | 8 | 2000 | 565 | 0.140 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2018 | 11 | 0.140 |
Why?
|
| Calcium | 4 | 1992 | 339 | 0.130 |
Why?
|
| Ischemia | 1 | 2018 | 115 | 0.130 |
Why?
|
| Cardiac Output, Low | 2 | 1994 | 9 | 0.130 |
Why?
|
| Tachycardia | 1 | 1997 | 6 | 0.130 |
Why?
|
| Premedication | 1 | 1997 | 15 | 0.130 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1997 | 31 | 0.130 |
Why?
|
| Electroconvulsive Therapy | 1 | 1997 | 30 | 0.130 |
Why?
|
| Heart | 4 | 1995 | 177 | 0.130 |
Why?
|
| Pharyngitis | 1 | 2017 | 8 | 0.130 |
Why?
|
| Cardiac Output | 5 | 1995 | 33 | 0.130 |
Why?
|
| Preanesthetic Medication | 2 | 2002 | 3 | 0.120 |
Why?
|
| Mental Recall | 1 | 1996 | 47 | 0.120 |
Why?
|
| Adult | 10 | 2017 | 9259 | 0.120 |
Why?
|
| Random Allocation | 1 | 2017 | 247 | 0.120 |
Why?
|
| Cohort Studies | 1 | 2020 | 1840 | 0.120 |
Why?
|
| Incidence | 1 | 2019 | 1241 | 0.120 |
Why?
|
| Anesthesiology | 1 | 1996 | 46 | 0.120 |
Why?
|
| Pain, Postoperative | 1 | 2018 | 199 | 0.120 |
Why?
|
| Bronchial Diseases | 1 | 1995 | 4 | 0.110 |
Why?
|
| Hemoptysis | 1 | 1995 | 3 | 0.110 |
Why?
|
| Hodgkin Disease | 2 | 2011 | 16 | 0.110 |
Why?
|
| Physician-Patient Relations | 1 | 1996 | 179 | 0.110 |
Why?
|
| Patient Satisfaction | 1 | 1996 | 231 | 0.110 |
Why?
|
| Dopamine Agents | 1 | 1994 | 21 | 0.110 |
Why?
|
| Anesthesia, Inhalation | 2 | 2011 | 14 | 0.100 |
Why?
|
| Anesthesia, Intravenous | 3 | 1989 | 5 | 0.100 |
Why?
|
| Myocardial Infarction | 5 | 2000 | 466 | 0.090 |
Why?
|
| Hypertension | 2 | 1997 | 979 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2020 | 3416 | 0.090 |
Why?
|
| Critical Illness | 1 | 1993 | 87 | 0.090 |
Why?
|
| Magnesium Sulfate | 2 | 1991 | 13 | 0.090 |
Why?
|
| Calcium Chloride | 1 | 1992 | 3 | 0.090 |
Why?
|
| Dexmedetomidine | 1 | 2011 | 12 | 0.090 |
Why?
|
| Coronary Vasospasm | 1 | 1991 | 4 | 0.090 |
Why?
|
| Splanchnic Circulation | 1 | 2011 | 3 | 0.090 |
Why?
|
| Bradycardia | 1 | 2011 | 17 | 0.090 |
Why?
|
| Hypnotics and Sedatives | 1 | 2011 | 31 | 0.090 |
Why?
|
| Respiration, Artificial | 1 | 2011 | 98 | 0.080 |
Why?
|
| Kidney | 1 | 1994 | 521 | 0.080 |
Why?
|
| Biopsy | 1 | 2011 | 252 | 0.080 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2010 | 27 | 0.080 |
Why?
|
| Prosthesis Failure | 1 | 2010 | 51 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 1998 | 717 | 0.080 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2002 | 100 | 0.080 |
Why?
|
| Heart Valve Prosthesis | 1 | 2010 | 58 | 0.080 |
Why?
|
| Etomidate | 1 | 1989 | 5 | 0.080 |
Why?
|
| Drug Interactions | 4 | 1997 | 86 | 0.080 |
Why?
|
| Pentobarbital | 2 | 1988 | 4 | 0.070 |
Why?
|
| Heart Atria | 1 | 2009 | 81 | 0.070 |
Why?
|
| Ticlopidine | 1 | 2008 | 12 | 0.070 |
Why?
|
| Drug-Eluting Stents | 1 | 2008 | 14 | 0.070 |
Why?
|
| Anesthesia, Conduction | 1 | 2008 | 24 | 0.070 |
Why?
|
| Echocardiography | 1 | 2009 | 190 | 0.070 |
Why?
|
| Aspirin | 1 | 2008 | 59 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2016 | 854 | 0.070 |
Why?
|
| Monitoring, Intraoperative | 2 | 2006 | 40 | 0.070 |
Why?
|
| Neuromuscular Depolarizing Agents | 1 | 1988 | 5 | 0.070 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2008 | 79 | 0.070 |
Why?
|
| Medical Errors | 1 | 2007 | 34 | 0.060 |
Why?
|
| Cyclic AMP | 2 | 1998 | 55 | 0.060 |
Why?
|
| Intraoperative Care | 1 | 2006 | 52 | 0.060 |
Why?
|
| Blood Pressure | 6 | 2006 | 861 | 0.060 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2006 | 168 | 0.050 |
Why?
|
| Recovery of Function | 1 | 2006 | 239 | 0.050 |
Why?
|
| Myocardial Contraction | 5 | 1998 | 59 | 0.050 |
Why?
|
| Young Adult | 1 | 2011 | 2649 | 0.050 |
Why?
|
| Coronary Disease | 2 | 1997 | 226 | 0.050 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2002 | 6 | 0.050 |
Why?
|
| Sex Factors | 2 | 1996 | 655 | 0.050 |
Why?
|
| Anesthesia, General | 2 | 2006 | 30 | 0.050 |
Why?
|
| North Carolina | 1 | 2016 | 1300 | 0.050 |
Why?
|
| Age Factors | 3 | 1996 | 1179 | 0.040 |
Why?
|
| Time Factors | 5 | 2011 | 2205 | 0.040 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 1999 | 3 | 0.040 |
Why?
|
| Sufentanil | 2 | 1989 | 6 | 0.040 |
Why?
|
| Aorta, Abdominal | 1 | 1999 | 31 | 0.040 |
Why?
|
| Length of Stay | 2 | 1999 | 321 | 0.040 |
Why?
|
| Animals | 7 | 1997 | 8199 | 0.040 |
Why?
|
| Heparin | 2 | 1990 | 65 | 0.040 |
Why?
|
| Antioxidants | 1 | 1999 | 122 | 0.040 |
Why?
|
| Adrenergic Agonists | 1 | 1998 | 8 | 0.040 |
Why?
|
| Lymphocytes | 1 | 1998 | 56 | 0.030 |
Why?
|
| Heart Valves | 1 | 1998 | 16 | 0.030 |
Why?
|
| Heart Conduction System | 2 | 1988 | 76 | 0.030 |
Why?
|
| Myocardium | 2 | 1997 | 184 | 0.030 |
Why?
|
| Renal Circulation | 1 | 1997 | 12 | 0.030 |
Why?
|
| Sympathetic Nervous System | 1 | 1997 | 34 | 0.030 |
Why?
|
| Electrocardiography | 3 | 1999 | 623 | 0.030 |
Why?
|
| Nausea | 1 | 1997 | 49 | 0.030 |
Why?
|
| Chromonar | 1 | 1997 | 1 | 0.030 |
Why?
|
| Coumarins | 1 | 1997 | 1 | 0.030 |
Why?
|
| Myocardial Reperfusion | 1 | 1997 | 9 | 0.030 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 1997 | 19 | 0.030 |
Why?
|
| Hospital-Patient Relations | 1 | 1996 | 3 | 0.030 |
Why?
|
| Intraoperative Period | 2 | 1999 | 43 | 0.030 |
Why?
|
| Injections, Intravenous | 2 | 1999 | 99 | 0.030 |
Why?
|
| Telephone | 1 | 1996 | 61 | 0.030 |
Why?
|
| Stimulation, Chemical | 2 | 1995 | 16 | 0.030 |
Why?
|
| Pyridones | 1 | 1995 | 10 | 0.030 |
Why?
|
| General Surgery | 1 | 1996 | 84 | 0.030 |
Why?
|
| Anticoagulants | 1 | 1997 | 122 | 0.030 |
Why?
|
| Attitude to Health | 1 | 1996 | 138 | 0.030 |
Why?
|
| Triiodothyronine | 1 | 1995 | 8 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1995 | 10 | 0.030 |
Why?
|
| Diuresis | 1 | 1994 | 6 | 0.030 |
Why?
|
| Natriuresis | 1 | 1994 | 5 | 0.030 |
Why?
|
| Logistic Models | 1 | 1996 | 743 | 0.030 |
Why?
|
| Health Status | 1 | 1996 | 355 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 1994 | 99 | 0.030 |
Why?
|
| Splenectomy | 1 | 1974 | 22 | 0.030 |
Why?
|
| Dogs | 3 | 1988 | 126 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2011 | 3626 | 0.020 |
Why?
|
| Ventricular Function, Left | 3 | 2006 | 264 | 0.020 |
Why?
|
| Ephedrine | 1 | 1992 | 3 | 0.020 |
Why?
|
| Shock | 1 | 1993 | 34 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 1993 | 292 | 0.020 |
Why?
|
| Drug Combinations | 2 | 1989 | 101 | 0.020 |
Why?
|
| Pulmonary Artery | 2 | 1992 | 26 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 1992 | 97 | 0.020 |
Why?
|
| Hypocalcemia | 1 | 1991 | 14 | 0.020 |
Why?
|
| Nitroprusside | 1 | 1991 | 5 | 0.020 |
Why?
|
| Hypothermia, Induced | 1 | 1991 | 15 | 0.020 |
Why?
|
| Cardiomegaly | 1 | 1991 | 29 | 0.020 |
Why?
|
| Parathyroid Hormone | 1 | 1991 | 46 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 1993 | 312 | 0.020 |
Why?
|
| Whole Blood Coagulation Time | 1 | 1990 | 1 | 0.020 |
Why?
|
| Protamines | 1 | 1990 | 4 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 1991 | 93 | 0.020 |
Why?
|
| Pressure | 1 | 2010 | 69 | 0.020 |
Why?
|
| Critical Care | 1 | 2011 | 108 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2011 | 161 | 0.020 |
Why?
|
| Lorazepam | 1 | 1989 | 3 | 0.020 |
Why?
|
| Scopolamine | 1 | 1989 | 8 | 0.020 |
Why?
|
| Succinylcholine | 1 | 1989 | 6 | 0.020 |
Why?
|
| Equipment Safety | 1 | 1989 | 19 | 0.020 |
Why?
|
| Halothane | 1 | 1988 | 1 | 0.020 |
Why?
|
| Verapamil | 1 | 1988 | 8 | 0.020 |
Why?
|
| Atrioventricular Node | 1 | 1988 | 6 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2011 | 252 | 0.020 |
Why?
|
| Propranolol | 1 | 1988 | 17 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 1991 | 883 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2010 | 393 | 0.020 |
Why?
|
| Electrophysiology | 1 | 1988 | 76 | 0.020 |
Why?
|
| Edrophonium | 1 | 1987 | 1 | 0.020 |
Why?
|
| Isoflurane | 1 | 1987 | 1 | 0.020 |
Why?
|
| Blood Coagulation | 1 | 1987 | 15 | 0.020 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 1987 | 7 | 0.020 |
Why?
|
| Hypertension, Pulmonary | 1 | 1987 | 22 | 0.020 |
Why?
|
| Catheterization | 1 | 1987 | 55 | 0.020 |
Why?
|
| Lung Diseases | 1 | 1987 | 50 | 0.020 |
Why?
|
| Neuromuscular Junction | 1 | 1987 | 70 | 0.020 |
Why?
|
| Prognosis | 1 | 1991 | 1534 | 0.020 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2007 | 26 | 0.020 |
Why?
|
| Hemorrhage | 1 | 1987 | 95 | 0.020 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2007 | 46 | 0.020 |
Why?
|
| Renal Artery Obstruction | 1 | 2006 | 38 | 0.010 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2006 | 58 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2006 | 146 | 0.010 |
Why?
|
| Multivariate Analysis | 2 | 1998 | 651 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 2 | 1989 | 39 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 2240 | 0.010 |
Why?
|
| Stroke Volume | 2 | 1992 | 417 | 0.010 |
Why?
|
| Preoperative Care | 1 | 1999 | 125 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 1999 | 327 | 0.010 |
Why?
|
| Rabbits | 1 | 1997 | 219 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1998 | 839 | 0.010 |
Why?
|
| Milrinone | 1 | 1995 | 2 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1995 | 15 | 0.010 |
Why?
|
| Thyroxine | 1 | 1995 | 16 | 0.010 |
Why?
|
| Radioisotope Teletherapy | 1 | 1974 | 1 | 0.010 |
Why?
|
| Cobalt Radioisotopes | 1 | 1974 | 3 | 0.010 |
Why?
|
| Splenic Neoplasms | 1 | 1974 | 2 | 0.010 |
Why?
|
| Blood Cell Count | 1 | 1974 | 28 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 1974 | 46 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 1974 | 107 | 0.010 |
Why?
|
| Blood Platelets | 1 | 1974 | 59 | 0.010 |
Why?
|
| Leukocytes | 1 | 1974 | 60 | 0.010 |
Why?
|
| Spleen | 1 | 1974 | 84 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 1974 | 113 | 0.010 |
Why?
|
| Cardiac Volume | 1 | 1992 | 13 | 0.010 |
Why?
|
| Ventricular Function, Right | 1 | 1992 | 17 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 1992 | 32 | 0.010 |
Why?
|
| Placebos | 1 | 1992 | 68 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1995 | 897 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1992 | 106 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1991 | 25 | 0.010 |
Why?
|
| Hypotension, Controlled | 1 | 1991 | 1 | 0.010 |
Why?
|
| Magnesium | 1 | 1991 | 29 | 0.010 |
Why?
|
| Calcitriol | 1 | 1991 | 29 | 0.010 |
Why?
|
| Rats | 1 | 1995 | 1895 | 0.010 |
Why?
|
| Refractory Period, Electrophysiological | 1 | 1988 | 2 | 0.000 |
Why?
|
| Vecuronium Bromide | 1 | 1987 | 1 | 0.000 |
Why?
|
| Pancuronium | 1 | 1987 | 2 | 0.000 |
Why?
|
| Nitrous Oxide | 1 | 1987 | 3 | 0.000 |
Why?
|
| Platelet Count | 1 | 1987 | 23 | 0.000 |
Why?
|
| Atropine | 1 | 1987 | 19 | 0.000 |
Why?
|
| Child | 1 | 1974 | 2435 | 0.000 |
Why?
|
| Probability | 1 | 1987 | 155 | 0.000 |
Why?
|
| Equipment Design | 1 | 1987 | 178 | 0.000 |
Why?
|
| Regression Analysis | 1 | 1987 | 273 | 0.000 |
Why?
|
| Blood Pressure Determination | 1 | 1987 | 106 | 0.000 |
Why?
|
| Adolescent | 1 | 1974 | 3519 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 1987 | 757 | 0.000 |
Why?
|